CAR T-Cell Immunotherapy in Minority Patients with Lymphoma

Guido Ghilardi(Hospital of the University of Pennsylvania), Marco Ruella(University of Pennsylvania), Wei‐Ting Hwang(University of Pennsylvania), Connor B. Grady(University of Pennsylvania), Rebecca Yelton(University of Pennsylvania), Carmen E. Guerra(Novartis (Switzerland)), Levanto Schachter(Oregon Health & Science University), Elise A. Chong(University of Pennsylvania), Abigail Doucette(University of Pennsylvania), Linhui Chen(Hospital of the University of Pennsylvania), Stefan K. Barta(University of Pennsylvania), Giulia Gabrielli(University of Turin), Eneida R. Nemecek(Oregon Health & Science University), Hatcher J. Ballard(University of Pennsylvania), Alfred L. Garfall(University of Pennsylvania), Daniel J. Landsburg(UPMC Hillman Cancer Center), Andy I. Chen(Scripps Research Institute), Luca Paruzzo(Hospital of the University of Pennsylvania), David L. Porter(University of Pennsylvania), Staci Williamson(Oregon Health & Science University), Stephen J. Schuster(UPMC Hillman Cancer Center), Richard T. Maziarz(Oregon Health & Science University), Raymone Pajarillo(Hospital of the University of Pennsylvania), Sunita D. Nasta(University of Pennsylvania), Elizabeth Weber(Hospital of the University of Pennsylvania), Cara Curley(Hospital of the University of Pennsylvania), Jakub Svoboda(UPMC Hillman Cancer Center), Griffin White(Hospital of the University of Pennsylvania), Ositadimma Ugwuanyi(Hospital of the University of Pennsylvania)

NEJM Evidence

March 26, 2024

Cited by 20

Related Papers

|New England Journal of Medicine|2014|1.6k

|New England Journal of Medicine|2012|1.1k

|Journal of Clinical Oncology|2017|664

|Journal of Clinical Investigation|2016|554

|Nature Medicine|2021|523